Unmet Needs in Preventive Treatment of Migraine Enrico BentivegnaDilara OnanPaolo Martelletti COMMENTARY Open access 04 February 2023 Pages: 337 - 342
Two Perspectives on Dravet Syndrome: Viewpoints from the Clinician and the Caregiver Judith BluvsteinSusanna Wenniger COMMENTARY Open access 16 February 2023 Pages: 343 - 350
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus Jerome De SèzeLaurent SuchetPatrick Vermersch REVIEW Open access 24 December 2022 Pages: 351 - 369
Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review François-Xavier ChaletOrestis BriasoulisR. Loch Macdonald REVIEW Open access 07 January 2023 Pages: 371 - 390
Off-time Treatment Options for Parkinson’s Disease Margherita FabbriRaquel BarbosaOlivier Rascol REVIEW Open access 12 January 2023 Pages: 391 - 424
Correction to: Off-time Treatment Options for Parkinson’s Disease Margherita FabbriRaquel BarbosaOlivier Rascol Correction Open access 02 February 2023 Pages: 425 - 425
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel Celia Oreja-GuevaraAintzane RabanalJosé Luis Gómez-Palomares REVIEW Open access 07 February 2023 Pages: 427 - 439
Optic Nerve Sheath Fenestration for Progressive Visual Loss in Cerebral Venous Sinus Thrombosis: A Long-Term Retrospective Observational Study Zongshan LiLu ChengHui Chen ORIGINAL RESEARCH Open access 07 January 2023 Pages: 441 - 457
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease Michael J. SoileauFernando L. PaganMustafa S. Siddiqui ORIGINAL RESEARCH Open access 18 January 2023 Pages: 459 - 478
Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus Vicente VillanuevaJesús ArtalJulio Bobes ORIGINAL RESEARCH Open access 24 January 2023 Pages: 479 - 503
Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis Brett HauberRuss PaulsenDana B. DiBenedetti ORIGINAL RESEARCH Open access 10 February 2023 Pages: 505 - 527
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort Juliette PelleAnais R. BriantGilles Defer ORIGINAL RESEARCH Open access 10 February 2023 Pages: 529 - 542
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study Claudia A. ChiribogaClaudio Brunothe JEWELFISH Study Group ORIGINAL RESEARCH Open access 13 February 2023 Pages: 543 - 557
Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment Hongxia YangGuoyan QiPeng Liu ORIGINAL RESEARCH Open access 14 February 2023 Pages: 559 - 570
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease Dana B. DiBenedettiHeather MenneCarla Romano ORIGINAL RESEARCH Open access 15 February 2023 Pages: 571 - 595
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose Borje DarpoMichal GevaMichael R. Hayden ORIGINAL RESEARCH Open access 22 February 2023 Pages: 597 - 617
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews Ju-Hong MinMarco CapobiancoMarius Ringelstein ORIGINAL RESEARCH Open access 24 February 2023 Pages: 619 - 633
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews Marco CapobiancoMarius RingelsteinDean M. Wingerchuk ORIGINAL RESEARCH Open access 24 February 2023 Pages: 635 - 650
Discrete Choice Experiment to Understand Japanese Patients’ and Physicians’ Preferences for Preventive Treatments for Migraine Jaein SeoTommi TervonenAntje Tockhorn-Heidenreich ORIGINAL RESEARCH Open access 27 February 2023 Pages: 651 - 668
Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis Payam Tabaee DamavandiNatalia FabinSimona Lattanzi ORIGINAL RESEARCH Open access 28 February 2023 Pages: 669 - 686
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy Aliya JaberMeera PatelMatthew A. Tremblay BRIEF REPORT Open access 16 February 2023 Pages: 687 - 700
Correction to: Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series Mirla AvilaYuanyuan TanVictor M. Rivera Correction Open access 23 February 2023 Pages: 701 - 701